tiprankstipranks
Standard BioTools (LAB)
NASDAQ:LAB
Holding LAB?
Track your performance easily

Standard BioTools (LAB) Financial Statements

440 Followers

Standard BioTools Financial Overview

Standard BioTools's market cap is currently ―. The company's EPS TTM is $-0.709; its P/E ratio is -2.28; Standard BioTools is scheduled to report earnings on February 12, 2025, and the estimated EPS forecast is $-0.06. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 44.97M$ 37.20M$ 45.54M$ 28.19M$ 25.37M
Gross Profit$ 23.26M$ 14.91M$ 24.19M$ 13.57M$ 11.15M
EBIT$ -26.82M$ -45.66M$ -38.73M$ -18.84M$ -19.72M
EBITDA$ -26.11M$ -42.28M$ -33.54M$ -14.93M$ -15.74M
Net Income Common Stockholders$ -26.94M$ -45.72M$ -78.17M$ -19.78M$ -21.00M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 366.33M$ 394.71M$ 462.28M$ 114.89M$ 128.85M
Total Assets$ 681.54M$ 708.73M$ 777.67M$ 323.07M$ 339.29M
Total Debt$ 89.47M$ 90.55M$ 91.90M$ 98.21M$ 99.72M
Net Debt$ -276.86M$ -304.16M$ -370.38M$ -16.68M$ -29.13M
Total Liabilities$ 192.21M$ 198.47M$ 200.35M$ 159.87M$ 159.75M
Stockholders Equity$ 489.33M$ 510.26M$ 577.32M$ -148.05M$ -131.72M
Cash Flow-
Free Cash Flow$ -30.12M$ -40.99M$ -63.26M$ -14.14M$ -12.32M
Operating Cash Flow$ -27.87M$ -39.05M$ -62.48M$ -14.06M$ -11.41M
Investing Cash Flow$ -30.88M$ 50.26M$ 318.07M$ -13.12M$ -49.93M
Financing Cash Flow$ -2.00K$ -28.36M$ -19.73M$ -1.00M$ -1.16M
Currency in USD

Standard BioTools Earnings and Revenue History

Standard BioTools Debt to Assets

Standard BioTools Cash Flow

Standard BioTools Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis